(Q42991703)

12 November 2017

Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein (English)

1 reference

12 November 2017

1 reference

1 reference

2

Naoya Sakamoto

1 reference

12 November 2017

Yasuhiro Itsui

1

1 reference

12 November 2017

Sei Kakinuma

3

1 reference

12 November 2017

Mina Nakagawa

4

1 reference

12 November 2017

Yuko Sekine-Osajima

5

1 reference

12 November 2017

Megumi Tasaka-Fujita

6

1 reference

12 November 2017

Yuki Nishimura-Sakurai

7

1 reference

12 November 2017

Gouki Suda

8

1 reference

12 November 2017

Yuko Karakama

9

1 reference

12 November 2017

Kako Mishima

10

1 reference

12 November 2017

Machi Yamamoto

11

1 reference

12 November 2017

Takako Watanabe

12

1 reference

12 November 2017

Mayumi Ueyama

13

1 reference

12 November 2017

Yusuke Funaoka

14

1 reference

12 November 2017

Seishin Azuma

15

1 reference

12 November 2017

Mamoru Watanabe

16

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

12 November 2017

1 reference

12 November 2017

50

1 reference

12 November 2017

1727-1737

1 reference

12 November 2017

6

1 reference

Epidemiology of hepatitis C

12 November 2017

1 reference

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Antiviral actions of interferons

1 reference

7 January 2021

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

1 reference

7 January 2021

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

1 reference

7 January 2021

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

7 January 2021

Regulation of hepatitis C virus replication by interferon regulatory factor 1

1 reference

7 January 2021

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication

1 reference

7 January 2021

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

1 reference

7 January 2021

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha

1 reference

7 January 2021

Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs

1 reference

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

7 January 2021

Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity

1 reference

7 January 2021

Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity

1 reference

7 January 2021

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

1 reference

7 January 2021

How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP

1 reference

7 January 2021

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

1 reference

7 January 2021

Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor

1 reference

7 January 2021

To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon.

1 reference

7 January 2021

How cells respond to interferons

1 reference

7 January 2021

Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins

1 reference

7 January 2021

IFN-inducible GTPases and immunity to intracellular pathogens

1 reference

7 January 2021

Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity

1 reference

7 January 2021

A giant GTPase, very large inducible GTPase-1, is inducible by IFNs

1 reference

7 January 2021

Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages.

1 reference

7 January 2021

Cloning, expression, and characterization of a novel guanylate-binding protein, GBP3 in murine erythroid progenitor cells

1 reference

7 January 2021

Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro

1 reference

7 January 2021

Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus

1 reference

7 January 2021

Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of the third GTP-binding motif

1 reference

7 January 2021

GTPase properties of the interferon-induced human guanylate-binding protein 2

1 reference

7 January 2021

Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis

1 reference

7 January 2021

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

1 reference

7 January 2021

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

1 reference

7 January 2021

Noncytopathic Bovine Viral Diarrhea Virus Inhibits Double-Stranded RNA-Induced Apoptosis and Interferon Synthesis

1 reference

7 January 2021

Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein

1 reference

7 January 2021

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

7 January 2021

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

7 January 2021

Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23195

1 reference

12 November 2017

1 reference